Press Releases

Protalix BioTherapeutics Reports Third Quarter 2026 Financial and Business Results

November 10, 2026

Higher Single PRX-115 Doses Kept Plasma Uric Acid Levels Below Therapeutic Target for Longer Durations

November 9, 2026

Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026

November 3, 2026

Protalix BioTherapeutics to Present at the Stifel 2026 Healthcare Conference

October 26, 2026

Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences

September 8, 2026

Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results

August 12, 2026

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

August 5, 2026

Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results

May 13, 2026

Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026

May 6, 2026

Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

March 18, 2026